Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Sinovac Takes Steps toward Producing Swine Flu Vaccine

publication date: May 1, 2009

Sinovac Biotech (北京科兴生物制品有限公司) has taken action to apply its vaccine technology to the currently threatening strain of influenza, H1N1, commonly referred to as Swine flu. The company expects to receive a sample of the flu soon, which will enable Sinovac to begin manufacturing vaccine. Although Sinovac did not supply a time line for the process, a release quoted Weidong Yin, Sinovac’s Chairman, President and CEO, as saying, “Once this vaccine strain is available from the global health authorities, we will be ready to produce vaccine as needed." More details...

Stock Symbol: (NYSE Amex: SVA)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital